No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic.
Alivernini S, Petricca L, Perniola S, Fedele AL, Gigante MR, Capacci A, Paglionico A, Varriano V, De Lorenzis E, Lanzo L, Melpignano F, Rubortone P, Tanti G, Tur C, Bruno D, Gigante L, Natalello G, Verardi L, Di Mario C, Tolusso B, Mirone L, Lizzio MM, Zoli A, Peluso G, Bosello SL, Gremese E.
Alivernini S, et al. Among authors: zoli a.
Rheumatology (Oxford). 2020 Sep 1;59(9):2644-2646. doi: 10.1093/rheumatology/keaa388.
Rheumatology (Oxford). 2020.
PMID: 32728733
Free PMC article.
No abstract available.